Abbott Labs' Q1 beats views
at Investor's Business Daily - 39 mins ago
The medical-products giant reported EPS of 47 cents, up 12%, on sales of $4.9 bil, up 3%, with both results above analyst expectations. Abbott Laboratories (ABT) affirmed its full-year EPS guidance of $2.10$2.20. Leerink analyst Danielle Antalffy...
ABT: 48.35 (+1.23)
Abbott Laboratories (ABT) Stock Gained Today on Strong Earnings Beat
at The Street - 2 hrs 6 mins ago
Abbott Laboratories (ABT) shares rose after the company beat analysts' first quarter earnings and revenue expectations today.
ABT: 48.35 (+1.23)
Omnicare reportedly exploring sale; trading halted
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 2:33PM CDT
ABT: 48.35 (+1.23), OCR: 84.52 (+3.45)
Abbott Laboratories' (ABT) CEO Miles White on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Apr 22, 1:26PM CDT
ABT: 48.35 (+1.23)
Abbott Labs (ABT) Beats on Q1 Earnings, View Reiterated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 12:18PM CDT
Abbott Laboratories (ABT) reported first-quarter 2015 earnings of 47 cents per share, up 38.2% from the year-ago quarter and beat the Zacks Consensus Estimate of 42 cents.
ABT: 48.35 (+1.23), VRX: 206.93 (-3.92), SHPG: 253.58 (+3.70), MYL: 72.40 (-1.67)
How to Trade the Market's Most-Active Stocks
at The Street - Wed Apr 22, 12:02PM CDT
Keep these stocks on your trading radar.
ABT: 48.35 (+1.23), MCD: 97.84 (+2.97), EMC: 27.13 (+0.81), BABA: 82.05 (-0.37)
Abbott Laboratories (ABT) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Wed Apr 22, 11:53AM CDT
The following Abbott Laboratories (ABT) conference call took place on April 22, 2015, 09:00 AM ET. This is a transcript of that earnings call:
ABT: 48.35 (+1.23)
St. Jude, Abbott Labs Beat Q1 Expectations
at Investor's Business Daily - Wed Apr 22, 9:54AM CDT
Two medical-product giants were rising in the stock market early Wednesday after beating first-quarter expectations. St. Jude Medical (STJ) jumped 6.5% to a new high above 73 after it reported earnings of 91 cents a share, up 6% from the year-earlier...
ABT: 48.35 (+1.23), STJ: 73.55 (+4.43), ABBV: 64.52 (+0.91)
Today's Unusual Social Activity Stock: Abbott Laboratories (ABT)
at The Street - Wed Apr 22, 8:48AM CDT
Trade-Ideas LLC identified Abbott Laboratories (ABT) as an unusual social activity candidate
ABT: 48.35 (+1.23)
Abbott Labs (ABT) Beats On Earnings in Q1 - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 8:22AM CDT
Abbott Labs (ABT) Beats On Earnings in Q1
ABT: 48.35 (+1.23)
Abbott Laboratories (ABT) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Apr 22, 7:55AM CDT
ABT: 48.35 (+1.23)
Gilead Sciences Vs. AbbVie: Which Is A Better Buy?
Mycroft - at Seeking Alpha - Wed Apr 22, 7:49AM CDT
JNJ: 100.43 (+0.13), ABT: 48.35 (+1.23), PCYC: 256.98 (-0.77), GILD: 104.18 (-1.02), SHPG: 253.58 (+3.70), ABBV: 64.52 (+0.91)
Abbott Q1 revenues off 7%; EPS up 529%; guidance maintained
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 7:31AM CDT
ABT: 48.35 (+1.23)
Abbott beats Street 1Q forecasts
Automated Insights - Wed Apr 22, 6:57AM CDT
ABBOTT PARK, Ill. (AP) _ Abbott Laboratories (ABT) on Wednesday reported first-quarter net income of $2.29 billion.
ABT: 48.35 (+1.23)
Abbott Laboratories beats by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 6:50AM CDT
ABT: 48.35 (+1.23)
Abbott Reports First-Quarter 2015 Results
PR Newswire - Wed Apr 22, 6:45AM CDT
Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2015.
ABT: 48.35 (+1.23)
Notable earnings before Wednesday's open
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 4:30PM CDT
DHI: 27.03 (-1.53), MKTX: 88.66 (-1.35), NLSN: 46.10 (+0.27), SEIC: 45.99 (+0.68), AZZ: 46.11 (-0.02), HBAN: 11.03 (-0.14), TDY: 109.69 (+0.48), PCH: 37.47 (-0.65), WERN: 30.29 (-1.11), NS: 65.49 (+1.78), BABY: 41.64 (+1.71), APH: 56.81 (-1.35), TEL: 70.14 (+0.13), R: 97.95 (+1.15), ANGI: 6.46 (+0.31), EVR: 50.80 (+1.28), CFG: 25.49 (+0.45), SIX: 49.97 (+1.37), EMC: 27.13 (+0.81), OC: 42.28 (-0.61), WAB: 98.61 (+2.84), BK: 42.43 (+1.39), KO: 41.31 (+0.53), LAD: 102.54 (+0.04), ABT: 48.35 (+1.23), TMO: 130.69 (-3.75), TROW: 82.59 (-0.21), SONS: 7.89 (+0.05), ALV: 120.22 (-3.47), GNTX: 18.26 (+0.09), BA: 151.19 (-2.14), TUP: 67.25 (-2.60), KNX: 32.62 (+0.07), STJ: 73.55 (+4.43), MCD: 97.84 (+2.97), AN: 65.83 (+0.93)
Abbott Laboratories Set to Possibly Pullback After Yesterday's Rally of 1.05%
Comtex SmarTrend(R) - Tue Apr 21, 4:10PM CDT
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $46.72 to a high of $47.28. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $46.89 on volume of 8.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABT: 48.35 (+1.23)
Abbott Laboratories (ABT) Stock Advances Today Ahead of Wednesday's Earnings Release
at The Street - Tue Apr 21, 12:42PM CDT
Abbott Laboratories (ABT) shares are gaining today ahead of the release of the company's earnings results tomorrow morning before the market opens.
ABT: 48.35 (+1.23)
Abbott Laboratories (ABT) Crosses Pivot Point Resistance at $46.77
Comtex SmarTrend(R) - Tue Apr 21, 9:35AM CDT
Shares of Abbott Laboratories (NYSE:ABT) opened today above their pivot of $46.57 and have already reached the first level of resistance at $46.77. Should the shares continue to rise, the resistance pivots of $46.91 and $47.25 will be of interest.
ABT: 48.35 (+1.23)